How much is enough?
This is a question I often hear from folks who criticize people such as Elon Musk and Jeff Bezos for being incredibly rich.
The argument is that at some point, one has so much money that he or she can simply stop hoarding it and share it with others.
An honorable endeavor to be sure, but certainly not something that can or should be dictated by others. Some have gone as far as to suggest that a limit should be set on how much money some of these billionaires can make.
While I understand the frustration of watching so many people go hungry or so many people struggle to live paycheck to paycheck, it’s absolutely absurd to think you can dictate how much money a person can make — and even more absurd to suggest that we have the right to tell these folks how to spend their own money.
I thought about this after reading a Yahoo Finance article this morning about how comedian Kevin Hart got swindled out of $1.2 million by his personal shopper:
According to TMZ, the comedian’s personal shopper, Dylan Syer, is accused of defrauding Hart of $1.2 million between October 2017 and February 2019. New York prosecutors say Syer began working for Hart in 2015 and began building the actor’s trust through authorized purchases; however, as the years went by, Syer allegedly began using Hart’s credit card to pour money into his own account.
I don’t know what it’s like to have a personal shopper.
And even if I had Kevin Hart’s money (his net worth clocks in at around $200 million), I still wouldn’t pay someone to buy my clothes. But that doesn’t mean I have any right to tell Kevin Hart whether or not he should use HIS money to hire a personal shopper.
My point is this…
Just because someone is wealthy doesn’t mean he or she has to abide by the wishes and demands of those who aren’t rich.
That being said, thinking about Kevin Hart’s situation, I can’t stop myself from thinking about how, had he invested that $1.2 million in my top psychedelic stock pick, which is now up nearly 800% — instead of allowing himself to get swindled by a thief — that $1.2 million would now be worth more than $10 million.
Let me explain…
If you’re a regular reader of these pages, you know that I’ve been very bullish on the psychedelics space for the past two years — and for good reason.
Psychedelic medicines represent the next evolution in treatments for mental illness, brain trauma, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
I say this because I’ve spent the past two years poring through the research and interviewing the experts. And what I’m seeing is truly game-changing because current treatments on the market for all of these ailments are either highly ineffective or don’t work at all.
This is why the FDA has given breakthrough therapy status to a number of companies developing psychedelic medicines for a variety of brain-related diseases.
If you’re unfamiliar, breakthrough therapy status essentially allows the FDA to expedite clinical trials so it can get these medicines to market much faster. It’s an incredibly bullish indicator for biotech and pharma investors, to be sure.
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
Now, to give you an idea of the size of the potential market value for psychedelics, here’s a short list of illnesses and diseases that many believe can be treated — or even cured — using psychedelic medicines:
- Global market for depression and anxiety treatments: $19 billion by 2027
- Global market for drug addiction treatments: $31 billion by 2027
- Global market for traumatic brain injury treatments: $156 billion by 2024
- Global market for neurodegenerative diseases drugs: $62.7 billion by 2026
- Global market for ADHD treatments: $24.9 billion by 2025
- Global market for bipolar disorder treatments: $4.9 billion by 2025
- Global market for schizophrenia drugs: $7.9 billion by 2022
Combined, you’re looking at more than $300 million up for grabs.
That ain’t chump change, and that’s why I continue to invest — and profit handsomely — from the psychedelics market.
You should be doing the same.
And that’s why I put together this “Introduction to Psychedelics” report, so you can learn more about this space, as well as some of the companies that are absolutely crushing it.
Of course, if you’re already a billionaire and would rather spend your cash on personal shoppers and a fleet of yachts, I get it. Certainly, if I had Jeff Bezos’ scratch, I’d be swinging in a hammock in Hawaii right now, eating mangoes and playing my guitar.
But for most of us, that’s simply not an option. But what is an option is getting a piece of a market that is already shaping up to be the most lucrative of 2021.
Click here now to get started.
To a new way of life and a new generation of wealth… Jeff Siegel
@JeffSiegel on Twitter
Check us out on YouTube!Jeff is the founder and managing editor of Green Chip Stocks. For more on Jeff, go to his editor’s page.
Want to hear more from Jeff? Sign up to receive emails directly from him ranging from market commentaries to opportunities that he has his eye on.
